2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary - A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, American Association for Thoracic Surgery, American College of Radiology

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 2, 2010, Pages

  Hiratzka, Loren F ^a   Bakris, George L ^a   Beckman, Joshua A ^a   Bersin, Robert M ^a   Carr, Vincent F ^a   Casey Jr , Donald E ^a   Eagle, Kim A ^a   Hermann, Luke K ^a   Isselbacher, Eric M ^a   Kazerooni, Ella A ^a   Kouchoukos, Nicholas T ^a   Lytle, Bruce W ^a   Milewicz, Dianna M ^a   Reich, David L ^a   Sen, Souvik ^a   Shinn, Julie A ^a   Svensson, Lars G ^a   Williams, David M ^a  

^a NONE

Author keywords

ACC AHA Clinical Practice Guideline; Acute thoracic aortic disease presentation and evaluation; Emergency department; Genetic syndromes associated with thoracic aortic aneurysm; Intramural hematoma; Thoracic aortic aneurysm; Thoracic aortic disease; Thoracic aortic dissection

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; ENDOVASCULAR SURGERY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; REVIEW; SCREENING TEST; THORACIC AORTA ANEURYSM; THORAX RADIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 77955207611     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22537     Document Type: Review

References (226)

1. ACCF/AHA Task Force on Practice Guidelines. Manual for ACCF/AHA Guideline Writing Committees: Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines. Available at http://www.acc.org/qualityandscience/clinical/ manual/pdfs/methodology.pdf and http://circ.ahajournals.org/manual/. Accessed January 7, 2010.
2. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/ SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aoratic disease: a report of the American College of Cardiology Foundation/American Heart Asssociation Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55:e27-130.
3. Svensson LG, Rodriguez ER. Aortic organ disease epidemic, and why do balloons pop? Circulation. 2005;112:1082-4.
4. Svensson LG, Crawford ES. Cardiovascular and Vascular Disease of the Aorta. Philadelphia, PA: WB Saunders Co; 1997:184.
5. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease. Circulation. 2006;114:e84-231.
6. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-21.
7. Pannu H, Tran-Fadulu V, Papke CL, et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet. 2007;16:2453-62. (Pubitemid 47500631)
8. Kumar SR. Pathologic Basis of Disease. Philadelphia, PA: Elsevier Saunders, 2005.
9. Collins JS, Evangelista A, Nienaber CA, et al. Differences in clinical presentation, management, and outcomes of acute type A aortic dissection in patients with and without previous cardiac surgery. Circulation. 2004;110:II237-II242.
10. Razzouk A, Gundry S, Wang N, et al. Pseudoaneurysms of the aorta after cardiac surgery or chest trauma. Am Surg. 1993;59:818-23. (Pubitemid 24005729)
11. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, Am Heart Association. Circulation. 1995;92:1355-74.
12. He R, Guo DC, Estrera AL, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006;131:671-8.
13. Tang PC, Coady MA, Lovoulos C, et al. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation. 2005;112:1098-105. (Pubitemid 41216115)
14. Pannu H, Fadulu VT, Chang J, et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation. 2005;112:513-20. (Pubitemid 41060791)
15. Guo D, Pannu H, Tran-Fadula V, et al. Mutations in smooth muscle alpha-actin (ACTA2). Nat Genet. 2007;39:1488-93.
16. Segura AM, Luna RE, Horiba K, et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation. 1998;98:II331-II337.
17. Fedak PW, de Sa MP, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg. 2003;126:797-806. (Pubitemid 37151966)
18. Lemaire SA, Wang X, Wilks JA, et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res. 2005;123:40-8. (Pubitemid 40094643)
19. Lemaire SA, Pannu H, Tran-Fadulu V, et al. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med. 2007;4:167-71. (Pubitemid 46358844)
20. Ikonomidis JS, Jones JA, Barbour JR, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg. 2007;133:1028-36.
21. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349:160-9.
22. Salvarani C, Gabriel SE, O'Fallon WM, et al. The incidence of giant cell arteritis in Olmstead County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123:192-4.
23. Amis ES Jr, Butler PF, Applegate KE, et al. Am College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007;4:272-84.
24. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-84.
25. Shellock FG, Spinazzi A. MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol. 2008;191:1129-39.
26. Cascade PN, Leibel SA. Decision-making in radiotherapy for the cancer patient: the Am College of Radiology Appropriateness Criteria Project. CA Cancer J Clin. 1998;48:146-50.
27. International Commission on Radiological Protection (ICRP). Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1977;1.
28. McCollough CH, Bruesewitz MR, Kofler JM Jr. CT dose reduction and dose management tools: overview of available options. Radiographics. 2006;26:503-12.
29. Parker MS, Matheson TL, Rao AV, et al. Making the transition: the role of helical CT in the evaluation of potentially acute thoracic aortic injuries. AJR Am J Roentgenol. 2001;176:1267-72.
30. Johnston KW, Rutherford RB, Tilson MD, et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North Am Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1991;13:452-8.
31. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507-12. (Pubitemid 19214582)
32. Yoshida S, Akiba H, Tamakawa M, et al. Thoracic involvement of type A aortic dissection and intramural hematoma: diagnostic accuracy: comparison of emergency helical CT and surgical findings. Radiology. 2003;228:430-5. (Pubitemid 36910083)
33. Sommer T, Fehske W, Holzknecht N, et al. Aortic dissection: a comparative study of diagnosis with spiral CT. multiplanar transesophageal echocardiography, and MR imaging. Radiology. 1996;199:347-52. (Pubitemid 26121978)
34. Zeman RK, Berman PM, Silverman PM, et al. Diagnosis of aortic dissection: value of helical CT with multiplanar reformation and three-dimensional rendering. AJR Am J Roentgenol. 1995;164:1375-80.
35. Shiga T, Wajima Z, Apfel CC, et al. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med. 2006;166:1350-6. (Pubitemid 44036346)
36. Am College of Radiology. ACR CT Accreditation Clinical Image Quality Guide. Available at http://www.acr.org/accreditation/computed/qc-forms/image- guide.aspx. Accessed January 7, 2010.
37. Practice Guideline for the Performance and Interpretation of Computed Tomography Angiography. Available at http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/guidelines/dx/cardio/ct-angiography. aspx. Accessed January 7, 2010.
38. Prince MR, Narasimham DL, Jacoby WT, et al. Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol. 1996;166:1387-97.
39. Bogaert J, Meyns B, Rademakers FE, et al. Follow-up of aortic dissection: contribution of MR angiography for evaluation of the abdominal aorta and its branches. Eur Radiol. 1997;7:695-702. (Pubitemid 127723239)
40. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993;328:1-9. (Pubitemid 23011464)
41. Pereles FS, McCarthy RM, Baskaran V, et al. Thoracic aortic dissection and aneurysm: evaluation with nonenhanced true FISP MR angiography in less than 4 minutes. Radiology. 2002;223:270-4. (Pubitemid 34262677)
42. Fischer U, Vosshenrich R, Kopka L, et al. Dissection of the thoracic aorta: pre- and postoperative findings on turbo-FLASH MR images obtained in the plane of the aortic arch. AJR Am J Roentgenol. 1994;163:1069-72. (Pubitemid 24355693)
43. Pearson GD, Devereux R, Loeys B, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation. 2008;118:785-91.
44. Svensson LG, Crawford ES, Coselli JS, et al. Impact of cardiovascular operation on survival in the Marfan patient. Circulation. 1989;80:I233-I242.
45. Svensson LG, Blackstone EH, Feng J, et al. Are Marfan syndrome and marfanoid patients distinguishable on long-term follow-up? Ann Thorac Surg. 2007;83:1067-74.
46. Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38:343-9.
47. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788-98. (Pubitemid 44285584)
48. Williams JA, Loeys BL, Nwakanma LU, et al. Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease. Ann Thorac Surg. 2007;83:S757-S763.
49. Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10-25.
50. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med. 1999;340:1307-13.
51. Svensson LG, Khitin L. Aortic cross-sectional area/height ratio timing of aortic surgery in asymptomatic patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2002;123:360-1. (Pubitemid 34127130)
52. Wenstrup RJ, Meyer RA, Lyle JS, et al. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med. 2002;4:112-7.
53. Gupta PA, Putnam EA, Carmical SG, et al. Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat. 2002;19:39-48.
54. Gupta PA, Wallis DD, Chin TO, et al. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet. 2004;41:e56.
55. Adeola T, Adeleye O, Potts JL, et al. Thoracic aortic dissection in a patient with autosomal dominant polycystic kidney disease. J Natl Med Assoc. 2001;93:282-7. (Pubitemid 33613253)
56. Lee CC, Chang WT, Fang CC, et al. Sudden death caused by dissecting thoracic aortic aneurysm in a patient with autosomal dominant polycystic kidney disease. Resuscitation. 2004;63:93-6.
57. Purnell R, Williams I, Von Oppell U, et al. Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan's syndrome. Eur J Cardiothorac Surg. 2005;28:346-8. (Pubitemid 41020720)
58. Morgan JM, Coupe MO, Honey M, et al. Aneurysms of the sinuses of Valsalva in Noonan's syndrome. Eur Heart J. 1989;10:190-3. (Pubitemid 19081867)
59. Shachter N, Perloff JK, Mulder DG. Aortic dissection in Noonan's syndrome (46 XY turner). Am J Cardiol. 1984;54:464-5. (Pubitemid 14055791)
60. McElhinney DB, Krantz ID, Bason L, et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation. 2002;106:2567-74. (Pubitemid 35340693)
61. Albornoz G, Coady MA, Roberts M, et al. Familial thoracic aortic aneurysms and dissections: incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg. 2006;82:1400-5. (Pubitemid 44402354)
62. Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg. 1999;134:361-7. (Pubitemid 29282076)
63. Stheneur C, Collod-Beroud G, Faivre L, et al. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders Hum Mutat. 2008;29:E284-95.
64. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moya-moya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617-27.
65. Braverman AC, Guven H, Beardslee MA, et al. The bicuspid aortic valve. Curr Probl Cardiol. 2005;30:470-522.
66. Borger MA, David TE. Management of the valve and ascending aorta in adults with bicuspid aortic valve disease. Semin Thorac Cardiovasc Surg. 2005;17:143-7.
67. Svensson LG, Blackstone EH, Cosgrove DM III. Surgical options in young adults with aortic valve disease. Curr Probl Cardiol. 2003;28:417-80.
68. Svensson LG. Aortic valve stenosis and regurgitation: an overview of management. J Cardiovasc Surg (Torino). 2008;49:297-303. (Pubitemid 351833253)
69. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-29.
70. Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54:3310-8. (Pubitemid 44622103)
71. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors Circulation. 1994;90:1855-60.
72. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667-71. (Pubitemid 19201965)
73. Fields CE, Bower TC, Cooper LT, et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg. 2006;43:64-71. (Pubitemid 43083510)
74. Arend WP, Michel BA, Bloch DA, et al. The Am College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129-34.
75. Hunder GG, Bloch DA, Michel BA, et al. The Am College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-8.
76. Evaluation of diagnostic ('classification') criteria in Behcet's disease: towards internationally agreed criteria. The International Study Group for Behcet's disease. Br J Rheumatol. 1992;31:299-308.
77. Goie The HS, Steven MM, van der Linden SM, et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol. 1985;24:242-9.
78. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897-903.
79. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43:665-9. (Pubitemid 38229542)
80. von Kodolitsch Y, Schwartz AG, Nienaber CA. Clinical prediction of acute aortic dissection. Arch Intern Med. 2000;160:2977-82.
81. Meszaros I, Morocz J, Szlavi J, et al. Epidemiology and clinicopathology of aortic dissection. Chest. 2000;117:1271-8.
82. Spittell PC, Spittell JA Jr, Joyce JW, et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc. 1993;68:642-51.
83. Mehta RH, O'Gara PT, Bossone E, et al. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol. 2002;40:685-92. (Pubitemid 34925615)
84. Klompas M. Does this patient have an acute thoracic aortic dissection? JAMA. 2002;287:2262-72.
85. Armstrong WF, Bach DS, Carey LM, et al. Clinical and echo-cardiographic findings in patients with suspected acute aortic dissection. Am Heart J. 1998;136:1051-60.
86. Gaul C, Dietrich W, Friedrich I, et al. Neurological symptoms in type A aortic dissections. Stroke. 2007;38:292-7. (Pubitemid 46184297)
87. Roberts WC, Ko JM, Moore TR, et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation. 2006;114:422-9.
88. Svensson LG, Labib SB, Eisenhauer AC, et al. Intimal tear without hematoma: an important variant of aortic dissection that can elude current imaging techniques. Circulation. 1999;99:1331-6.
89. Chirillo F, Salvador L, Bacchion F, et al. Clinical and anatomical characteristics of subtle-discrete dissection of the ascending aorta. Am J Cardiol. 2007;100:1314-9. (Pubitemid 47498290)
90. Murray CA, Edwards JE. Spontaneous laceration of ascending aorta. Circulation. 1973;47:848-58.
91. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. J Am Coll Cardiol. 2004;44:671-719.
92. Erbel R, Engberding R, Daniel W, et al. Echocardiography in diagnosis of aortic dissection. Lancet. 1989;1:457-61.
93. Borner N, Erbel R, Braun B, et al. Diagnosis of aortic dissection by transesophageal echocardiography. Am J Cardiol. 1984;54:1157-8. (Pubitemid 15211620)
94. Deleted in proof.
95. Suzuki T, Mehta RH, Ince H, et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation. 2003;108(suppl 1):II312-II317.
96. Estrera AL, Miller CC III, Safi HJ, et al. Outcomes of medical management of acute type B aortic dissection. Circulation. 2006;114:I384-I389.
97. Umana JP, Lai DT, Mitchell RS, et al. Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections? J Thorac Cardiovasc Surg. 2002;124:896-910.
98. Mehta RH, Suzuki T, Hagan PG, et al. Predicting death in patients with acute type A aortic dissection. Circulation. 2002;105:200-6. (Pubitemid 34084319)
99. Chiappini B, Schepens M, Tan E, et al. Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur Heart J. 2005;26:180-6. (Pubitemid 40282787)
100. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. J Am Coll Cardiol. 2009;53:530-53.
101. Townsend CM, Beauchamp RD, Evers BM, et al. Sabiston Textbook of Surgery. 18th ed. Philadelphia: Elsevier Health Sciences, 2008.
102. Libby P, Bonow RO, Mann DL, et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia: 2007.
103. Isselbacher E. Cecil Medicine. 23rd ed. Philadelphia: Elsevier Health Sciences, 2008.
104. Genoni M, Paul M, Jenni R, et al. Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg. 2001;19:606-10. (Pubitemid 32416612)
105. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994;330:1335-41. (Pubitemid 24984696)
106. Ladouceur M, Fermanian C, Lupoglazoff JM, et al. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol. 2007;99:406-9. (Pubitemid 46149560)
107. Ahimastos AA, Aggarwal A, D'Orsa KM, et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA. 2007;298:1539-47. (Pubitemid 47529388)
108. Mochizuki S, Dahlof B, Shimizu M, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet. 2007;369:1431-9.
109. Brooke BS, Habashi JP, Judge DP, et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008;358:2787-95.
110. Diehm N, Becker G, Katzen B, et al. Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. Vasa. 2008;37:241-9.
111. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97.
112. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol. 2001;38:2101-13.
113. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13. (Pubitemid 35472129)
114. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration Lancet. 2000;356:1955-64.
115. Ogden LG, He J, Lydick E, et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35:539-43. (Pubitemid 30108145)
116. Lacro RV, Dietz HC, Wruck LM, et al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007;154:624-31.
117. Evans J, Powell JT, Schwalbe E, et al. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg. 2007;34:302-3. (Pubitemid 47194427)
118. Leurs LJ, Visser P, Laheij RJ, et al. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular. 2006;14:1-8.
119. Kurzencwyg D, Filion KB, Pilote L, et al. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair. Ann Vasc Surg. 2006;20:569-76. (Pubitemid 44953069)
120. Yilmaz MB, Biyikoglu SF, Guray Y, et al. Level of awareness of on-treatment patients about prescribed statins. Cardiovasc Drugs Ther. 2004;18:399-404. (Pubitemid 40558207)
121. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1-e157.
122. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the Am Heart Association. Am Heart Association Task Force on Risk Reduction. Circulation. 1997;96:3243-7.
123. Daly LE, Mulcahy R, Graham IM, Hickay N. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J (Clin Res Ed). 1983;287:324-6.
124. U.S. Department of Health and Human Services, Public Health Service Agency. Clinical Practice Guidelines: Number 18: Smoking Cessation. 1996; AHCPR Publication 96-0692.
125. Svensson LG, Kouchoukos NT, Miller DC, et al. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85:S1-41.
126. Kouchoukos NT, Dougenis D. Surgery of the thoracic aorta. N Engl J Med. 1997;336:1876-88.
127. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74:S1877-S1880.
128. Boissonnas CC, Davy C, Bornes M, et al. Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil Steril. 2009;91:929-7.
129. Svensson LG, Kim KH, Lytle BW, et al. Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg. 2003;126:892-3.
130. Tzemos N, Therrien J, Yip J, et al. Outcomes in adults with bicuspid aortic valves. JAMA. 2008;300:1317-25.
131. Vallely MP, Semsarian C, Bannon PG. Management of the ascending aorta in patients with bicuspid aortic valve disease. Heart Lung Circ. 2008;17:357-63.
132. Vaughan CJ, Casey M, He J, et al. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation. 2001;103:2469-75. (Pubitemid 32493373)
133. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004;24:1161-70. (Pubitemid 38880003)
134. Iribarren C, Sidney S, Sternfeld B, et al. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000;283:2810-5. (Pubitemid 30387825)
135. Chiu KM, Lin TY, Chen JS, et al. Images in cardiovascular medicine. Left ventricle apical conduit to bilateral subclavian artery in a patient with porcelain aorta and aortic stenosis. Circulation. 2006;113:e388-e389.
136. Svensson LG, Blackstone EH, Rajeswaran J, et al. Does the arterial cannulation site for circulatory arrest influence stroke risk? Ann Thorac Surg. 2004;78:1274-84.
137. Crawford ES, Kirklin JW, Naftel DC, et al. Surgery for acute dissection of ascending aorta. Should the arch be included? J Thorac Cardiovasc Surg. 1992;104:46-59.
138. Svensson LG, Crawford ES, Hess KR, et al. Dissection of the aorta and dissecting aortic aneurysms. Improving early and long-term surgical results. Circulation. 1990;82:IV24-IV38.
139. Greenberg RK, Haddad F, Svensson L, et al. Hybrid approaches to thoracic aortic aneurysms: the role of endovascular elephant trunk completion. Circulation. 2005;112:2619-26. (Pubitemid 41532598)
140. Svensson LG. The elephant trunk procedure: uses in complex aortic diseases. Curr Opin Cardiol. 2005;20:491-5.
141. Svensson LG, Kim KH, Blackstone EH, et al. Elephant trunk procedure: newer indications and uses. Ann Thorac Surg. 2004;78:109-16.
142. Coady MA, Rizzo JA, Hammond GL, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg. 1997;113:476-91.
143. Estrera AL, Rubenstein FS, Miller CC III, et al. Descending thoracic aortic aneurysm: surgical approach and treatment using the adjuncts cerebrospinal fluid drainage and distal aortic perfusion. Ann Thorac Surg. 2001;72:481-6.
144. Svensson LG, Crawford ES, Hess KR, et al. Variables predictive of outcome in 832 patients undergoing repairs of the descending thoracic aorta. Chest. 1993;104:1248-53.
145. Matsumura JS, Cambria RP, Dake MD, et al. International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg. 2008;47:247-57.
146. Svensson LG, Crawford ES, Hess KR, et al. Thoracoabdominal aortic aneurysms associated with celiac, superior mesenteric, and renal artery occlusive disease: methods and analysis of results in 271 patients. J Vasc Surg. 1992;16:378-89.
147. Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150-7.
148. Immer FF, Bansi AG, Immer-Bansi AS, et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg. 2003;76:309-14.
149. Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320-5.
150. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16.
151. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-804.
152. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in highrisk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J AmColl Cardiol. 2007;49:1763-9.
153. Practice guidelines for perioperative transesophageal echocardiography. A report by the Am Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology. 1996;84:986-1006.
154. Fattori R, Caldarera I, Rapezzi C, et al. Primary endoleakage in endovascular treatment of the thoracic aorta: importance of intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg. 2000;120:490-5.
155. Abe S, Ono S, Murata K, et al. Usefulness of transesophageal echocardiographic monitoring in transluminal endovascular stent-graft repair for thoracic aortic aneurysm. Jpn Circ J. 2000;64:960-4.
156. Dong CC, MacDonald DB, Janusz MT. Intraoperative spinal cord mon itoring during descending thoracic and thoracoabdominal aneurysm surgery. Ann Thorac Surg. 2002;74:S1873-S1876.
157. Meylaerts SA, Jacobs MJ, van Iterson V, et al. Comparison of transcranial motor evoked potentials and somatosensory evoked potentials during thoracoabdominal aortic aneurysm repair. Ann Surg. 1999;230:742-9.
158. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172-97. (Pubitemid 36618311)
159. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27-S86.
160. Akashi H, Tayama K, Fujino T, et al. Cerebral protection selection in aortic arch surgery for patients with preoperative complications of cerebrovascular disease. Jpn J Thorac Cardiovasc Surg. 2000;48:782-8.
161. Ehrlich MP, Fang WC, Grabenwoger M, et al. Impact of retrograde cerebral perfusion on aortic arch aneurysm repair. J Thorac Cardiovasc Surg. 1999;118:1026-32.
162. Di Eusanio M, Wesselink RM, Morshuis WJ, et al. Deep hypothermic circulatory arrest and antegrade selective cerebral perfusion during ascending
163. Hagl C, Ergin MA, Galla JD, et al. Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg. 2001;121:1107-21. (Pubitemid 33733661)
164. Reich DL, Uysal S, Sliwinski M, et al. Neuropsychologic outcome after deep hypothermic circulatory arrest in adults. J Thorac Cardiovasc Surg. 1999;117:156-63. (Pubitemid 29022261)
165. Reich DL, Uysal S, Ergin MA, et al. Retrograde cerebral perfusion during thoracic aortic surgery and late neuropsychological dysfunction. Eur J Cardiothorac Surg. 2001;19:594-600. (Pubitemid 32416610)
166. Usui A, Yasuura K, Watanabe T, et al. Comparative clinical study between retrograde cerebral perfusion and selective cerebral perfusion in surgery for acute type A aortic dissection. Eur J Cardiothorac Surg. 1999;15:571-8. (Pubitemid 29251749)
167. Kunihara T, Grun T, Aicher D, et al. Hypothermic circulatory arrest is not a risk factor for neurologic morbidity in aortic surgery: a propensity score analysis. J Thorac Cardiovasc Surg. 2005;130:712-8. (Pubitemid 41265709)
168. Schepens MA, Dossche KM, Morshuis WJ, et al. The elephant trunk technique: operative results in 100 consecutive patients. Eur J Cardiothorac Surg. 2002;21:276-81.
169. Deeb GM, Williams DM, Quint LE, et al. Risk analysis for aortic surgery using hypothermic circulatory arrest with retrograde cerebral perfusion. Ann Thorac Surg. 1999;67:1883-6.
170. Ehrlich MP, Schillinger M, Grabenwoger M, et al. Predictors of adverse outcome and transient neurological dysfunction following surgical treatment of acute type A dissections. Circulation. 2003;108(suppl 1):II318-II323.
171. Fleck TM, Czerny M, Hutschala D, et al. The incidence of transient neurologic dysfunction after ascending aortic replacement with circulatory arrest. Ann Thorac Surg. 2003;76:1198-202.
172. Moshkovitz Y, David TE, Caleb M, et al. Circulatory arrest under moderate systemic hypothermia and cold retrograde cerebral perfusion. Ann Thorac Surg. 1998;66:1179-84. (Pubitemid 28518047)
173. Okita Y, Takamoto S, Ando M, et al. Mortality and cerebral outcome in patients who underwent aortic arch operations using deep hypothermic circulatory arrest with retrograde cerebral perfusion: no relation of early death, stroke, and delirium to the duration of circulatory arrest. J Thorac Cardiovasc Surg. 1998;115:129-38. (Pubitemid 28082158)
174. Ueda Y, Okita Y, Aomi S, et al. Retrograde cerebral perfusion for aortic arch surgery: analysis of risk factors. Ann Thorac Surg. 1999;67:1879-82. (Pubitemid 29301370)
175. Wong CH, Bonser RS. Does retrograde cerebral perfusion affect risk factors for stroke and mortality after hypothermic circulatory arrest? Ann Thorac Surg. 1999;67:1900-3.
176. Di Eusanio M, Schepens MA, Morshuis WJ, et al. Brain protection using antegrade selective cerebral perfusion: a multicenter study. Ann Thorac Surg. 2003;76:1181-8.
177. Di Eusanio M, Schepens MA, Morshuis WJ, et al. Antegrade selective cerebral perfusion during operations on the thoracic aorta: factors influencing survival and neurologic outcome in 413 patients. J Thorac Cardiovasc Surg. 2002;124:1080-6. (Pubitemid 35416993)
178. Di Eusanio M, Tan ME, Schepens MA, et al. Surgery for acute type A dissection using antegrade selective cerebral perfusion: experience with 122 patients. Ann Thorac Surg. 2003;75:514-9. (Pubitemid 36184501)
179. Kazui T, Yamashita K, Washiyama N, et al. Impact of an aggressive surgical approach on surgical outcome in type A aortic dissection. Ann Thorac Surg. 2002;74:S1844-S1847. (Pubitemid 35222715)
180. Kazui T, Yamashita K, Washiyama N, et al. Aortic arch replacement using selective cerebral perfusion. Ann Thorac Surg. 2007;83:S796-S798.
181. Numata S, Ogino H, Sasaki H, et al. Total arch replacement using antegrade selective cerebral perfusion with right axillary artery perfusion. Eur J Cardiothorac Surg. 2003;23:771-5. (Pubitemid 36566572)
182. Sasaki H, Ogino H, Matsuda H, et al. Integrated total arch replacement using selective cerebral perfusion: a 6-year experience. Ann Thorac Surg. 2007;83:S805-S810. (Pubitemid 46135494)
183. Strauch JT, Spielvogel D, Lauten A, et al. Axillary artery cannulation: routine use in ascending aorta and aortic arch replacement. Ann Thorac Surg. 2004;78:103-8. (Pubitemid 38833908)
184. Kamiya H, Hagl C, Kropivnitskaya I, et al. Quick proximal arch replacement with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2007;83:1055-8. (Pubitemid 46328812)
185. Matalanis G, Hata M, Buxton BF. A retrospective comparative study of deep hypothermic circulatory arrest, retrograde, and antegrade cerebral perfusion in aortic arch surgery. Ann Thorac Cardiovasc Surg. 2003;9:174-9.
186. Okita Y, Minatoya K, Tagusari O, et al. Prospective comparative study of brain protection in total aortic arch replacement: deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion. Ann Thorac Surg. 2001;72:72-9. (Pubitemid 32643012)
187. Zierer A, Aybek T, Risteski P, et al. Moderate hypothermia (30 degrees C) for surgery of acute type A aortic dissection. Thorac Cardiovasc Surg. 2005;53:74-9. (Pubitemid 40545325)
188. Svensson LG, Nadolny EM, Kimmel WA. Multimodal protocol influence on stroke and neurocognitive deficit prevention after ascending/arch aortic operations. Ann Thorac Surg. 2002;74:2040-6.
189. Okita Y, Ando M, Minatoya K, et al. Predictive factors for mortality and cerebral complications in arteriosclerotic aneurysm of the aortic arch. Ann Thorac Surg. 1999;67:72-8. (Pubitemid 29138732)
190. Svensson LG, Crawford ES, Hess KR, et al. Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients. J Thorac Cardiovasc Surg. 1993;106:19-28.
191. Grigore AM, Grocott HP, Mathew JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg. 2002;94:4-10, table.
192. Grocott HP, Mackensen GB, Grigore AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke. 2002;33:537-41.
193. Bar-Yosef S, Mathew JP, Newman MF, et al. Prevention of cerebral hyperthermia during cardiac surgery by limiting onbypass rewarming in combination with post-bypass body surface warming: a feasibility study. Anesth Analg. 2004;99:641-6. (Pubitemid 39100346)
194. Coselli JS, Lemaire SA, Koksoy C, et al. Cerebrospinal fluid drainage reduces paraplegia after thoracoabdominal aortic aneurysm repair: results of a randomized clinical trial. J Vasc Surg. 2002;35:631-9. (Pubitemid 46300073)
195. Khan SN, Stansby G. Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery. Cochrane Database Syst Rev. 2004;CD003635.
196. Safi HJ, Miller CC III, Huynh TT, et al. Distal aortic perfusion and cerebrospinal fluid drainage for thoracoabdominal and descending thoracic aortic repair: ten years of organ protection. Ann Surg. 2003;238:372-80.
197. Estrera AL, Miller CC III, Chen EP, et al. Descending thoracic aortic aneurysm repair: 12-year experience using distal aortic perfusion and cerebrospinal fluid drainage. Ann Thorac Surg. 2005;80:1290-6.
198. Safi HJ, Hess KR, Randel M, et al. Cerebrospinal fluid drainage and distal aortic perfusion: reducing neurologic complications in repair of thoracoabdominal aortic aneurysm types I and II. J Vasc Surg. 1996;23:223-8.
199. Hollier LH, Money SR, Naslund TC, et al. Risk of spinal cord dysfunction in patients undergoing thoracoabdominal aortic replacement. Am J Surg. 1992;164:210-3.
200. Svensson LG, Khitin L, Nadolny EM, et al. Systemic temperature and paralysis after thoracoabdominal and descending aortic operations. Arch Surg. 2003;138:175-9. (Pubitemid 36216282)
201. Cambria RP, Davison JK, Carter C, et al. Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair: a five-year experience. J Vasc Surg. 2000;31:1093-102.
202. Cambria RP, Davison JK, Zannetti S, et al. Clinical experience with epidural cooling for spinal cord protection during thoracic and thoracoabdominal aneurysm repair. J Vasc Surg. 1997;25:234-41.
203. Woloszyn TT, Marini CP, Coons MS, et al. Cerebrospinal fluid drainage and steroids provide better spinal cord protection during aortic cross-clamping than does either treatment alone. Ann Thorac Surg. 1990;49:78-82.
204. Schurink GW, Nijenhuis RJ, Backes WH, et al. Assessment of spinal cord circulation and function in endovascular treatment of thoracic aortic aneurysms. Ann Thorac Surg. 2007;83:S877-81.
205. Ogino H, Sasaki H, Minatoya K, et al. Combined use of adamkiewicz artery demonstration and motor-evoked potentials in descending and thoracoabdominal repair. Ann Thorac Surg. 2006;82:592-6. (Pubitemid 44080036)
206. Guerit JM, Witdoeckt C, Verhelst R, et al. Sensitivity, specificity, and surgical impact of somatosensory evoked potentials in descending aorta surgery. Ann Thorac Surg. 1999;67:1943-6. (Pubitemid 29301386)
207. Jacobs MJ, de Mol BA, Legemate DA, et al. Retrograde aortic and selective organ perfusion during thoracoabdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 1997;14:360-6.
208. Koksoy C, Lemaire SA, Curling PE, et al. Renal perfusion during thoracoabdominal aortic operations: cold crystalloid is superior to nor-mothermic blood. Ann Thorac Surg. 2002;73:730-8. (Pubitemid 34189268)
209. Svensson LG, Coselli JS, Safi HJ, et al. Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or thoracoabdominal aorta. J Vasc Surg. 1989;10:230-9.
210. Perdue PW, Balser JR, Lipsett PA, et al. "Renal dose" dopamine in surgical patients: dogma or science? Ann Surg. 1998;227:470-3.
211. Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996;126:666-73. (Pubitemid 26145215)
212. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002;73:17-27.
213. Davies RR, Kaple RK, Mandapati D, et al. Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg. 2007;83:1338-44. (Pubitemid 46440756)
214. Erbel R, Alfonso F, Boileau C, et al. Diagnosis and management of aortic dissection. Eur Heart J. 2001;22:1642-81.
215. Williams MA, Haskell WL, Ades PA, et al. Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the Am Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2007;116:572-84.
216. Palatini P, Mos L,Munari L, et al. Blood pressure changes during heavy-resistance exercise. J Hypertens Suppl. 1989;7:S72-3.
217. Hatzaras I, Tranquilli M, Coady M, et al. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107:103-6. (Pubitemid 46272259)
218. Deslauriers J, Gregoire J. Clinical and surgical staging of nonsmall cell lung cancer. Chest. 2000;117:96S-103S. (Pubitemid 30225147)
219. Kameda K, Adachi S, Kono M. Detection of T-factor in lung cancer using magnetic resonance imaging and computed tomography. J Thorac Imaging. 1988;3:73-80. (Pubitemid 19034406)
220. Ohtsuka T, Minami M, Nakajima J, et al. Cine computed tomography for evaluation of tumors invasive to the thoracic aorta: seven clinical experiences. J Thorac Cardiovasc Surg. 1996;112:190-2. (Pubitemid 26268989)
221. Schroder C, Schonhofer B, Vogel B. Transesophageal echographic determination of aortic invasion by lung cancer. Chest. 2005;127:438-42. (Pubitemid 40229300)
222. Oldenburg WA. Primary Tumors of Major Blood Vessels.6th ed. Philadelphia: Elsevier Saunders, 2005:1665.
223. Chen WJ, Chen CL, Liau CS, et al. Primary malignant fibrous histiocytoma of the aorta associated with aortic dissection. Chest. 1991;99:1049-50.
224. Utsunomiya D, Ikeda O, Ideta I, et al. Malignant fibrous histiocytoma arising from the aortic wall mimicking a pseudoaneurysm with ulceration. Circ J. 2007;71:1659-61. (Pubitemid 47529674)
225. Guttentag A, Lazar HL, Franklin P, et al. Malignant fibrous histiocytoma obstructing the thoracic aorta. Ann Thorac Surg. 1989;47:775-7. (Pubitemid 19141041)
226. Kouchoukos NT, Masetti P. Primary sarcoma of the thoracic aorta. Ann Thorac Surg. 2007;83:e1.